Tag: Lifesciences
Edwards Lifesciences launches India’s most advanced Transcatheter Heart Valve
Next-generation technology delivers unmatched durability and minimally invasive treatment for aortic stenosis patients
Zydus Therapeutics announces positive phase 2b/3 results for Saroglitazar in primary...
EPICS-III trial met primary and key secondary endpoints, with Saroglitazar demonstrating significant efficacy, good tolerability, and paving the way for a planned U.S. regulatory submission in early 2026
Telangana emerges as a global life sciences hub with over Rs...
Hyderabad is currently ranked among the world’s top seven life sciences clusters and remains the only Indian city on the list
Zydus Lifesciences posts 6% revenue growth in Q1 FY26, Net profit...
Strong performance in chronic therapies, robust international growth, and strategic acquisitions bolster the company’s innovation pipeline and global presence
Zydus Medtech and Braile Biomedica of Brazil announce global licensing pact...
The company gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets
Veeda Group rebrands as Veeda Lifesciences
Veeda Lifesciences represents the brand that integrates Veeda Clinical Research, Health Data Specialists, and Bioneeds India
Experts discuss strengthening Indo-Belgian life-sciences corridor
About 200 participants, including researchers, policymakers, and industry leaders from India and Belgium, addressed global healthcare challenges and explored collaborative opportunities
LSI hosts global conference ‘Vishwa Swasthyam 2024’ on prediabetes
The event highlighted the concerning surge of prediabetes, an often-overlooked condition affecting millions globally, and its crucial contribution to the escalating diabetes crisis in India
BioAsia 2024 to put spotlight on role of data & AI...
The annual event dedicated to the life sciences sector, is gearing up to set a new standard with its 21st edition, BioAsia 2024, scheduled from February 26 to 28, 2024
Zydus to present on ZYIL1 at the International Congress of Parkinson’s...
ZYIL1 decreased α synuclein expression and improved motor function in non-clinical models
of Parkinson’s Disease